Nimodipine: Aneurysmal Subarachnoid Hemorrhage, Enteral Dosing and Safety

Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling. Overview and correct indication Nimodipine is a lipophilic dihydropyridine L-type calcium channel blocker with an established role in improving neurologic outcomes following aneurysmal subarachnoid hemorrhage (aSAH). Although its vascular effects may reduce calcium-dependent vasoconstriction,…

Read Full News

Nifedipine: Dihydropyridine Calcium Blockade, Extended-Release Therapy and Precautions

Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling. Overview and correct chemistry Nifedipine is a dihydropyridine calcium channel blocker used in hypertension and chronic angina and for selected pregnancy-related and vasospastic disorders under protocol. The chemical formula is C17H18N2O6, and its aromatic…

Read Full News

Valsartan: AT1 Receptor Blockade, Heart Failure, Renal Monitoring and Fetal Toxicity

Evidence-informed pharmacology monograph updated 10 November 2026. Educational content, not a substitute for patient-specific assessment, institutional protocols or current product labeling. Overview and chemical identity Valsartan is a selective nonpeptide angiotensin II type 1 (AT1) receptor antagonist (ARB), used for hypertension, certain heart-failure regimens and post-myocardial-infarction left ventricular dysfunction. Its correct empirical formula is C24H29N5O3;…

Read Full News

Telmisartan Monograph: AT1 Receptor Blockade, Cardiovascular Prevention and Renal Safety

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview and classification Telmisartan is a nonpeptide angiotensin II receptor blocker (ARB), containing two benzimidazole groups and a biphenyl carboxylic acid moiety; the previous article’s elaborate imidazopyrimidine/piperazine chemical name was incorrect. Telmisartan antagonizes angiotensin II AT1…

Read Full News

Acetazolamide Monograph: Carbonic Anhydrase Inhibition, Altitude Illness and Acidosis

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview Acetazolamide is a systemic sulfonamide carbonic anhydrase inhibitor, used for altitude illness prophylaxis/treatment, selected glaucoma indications, intracranial hypertension, epilepsy and certain edema or alkalosis scenarios. It is a relatively weak diuretic compared with loop diuretics…

Read Full News

Dextromethorphan Monograph: Cough Suppression, CYP2D6 and Serotonin Syndrome

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview and structure Dextromethorphan is a synthetic dextrorotatory morphinan used as a centrally acting nonopioid antitussive at recommended doses. It is structurally related to opioid compounds but has little clinically meaningful mu-opioid agonist activity at usual…

Read Full News

Acetylcysteine Monograph: Glutathione Replenishment, Mucolysis and Paracetamol Antidote

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview N-acetylcysteine (NAC; acetylcysteine) is used as an antidote for acetaminophen/paracetamol poisoning and as a mucolytic in selected respiratory conditions. Mechanisms include supplying cysteine for glutathione synthesis and reducing disulfide bonds in mucoproteins. Evidence for unapproved…

Read Full News

Fluticasone Monograph: Inhaled, Intranasal and Topical Corticosteroid Safety

Evidence-informed pharmacology monograph updated 10 November 2026. For education only; use current local labeling, clinical guidance and individual assessment. Overview and formulations Fluticasone is a potent synthetic glucocorticoid available as different ester formulations, including fluticasone propionate and fluticasone furoate, with inhaled, intranasal and topical products. They are not interchangeable milligram-for-milligram. Inhaled corticosteroids (ICS) control airway…

Read Full News

Budesonide Monograph: Glucocorticoid Pharmacology, Asthma, GI Formulations and Safety

Evidence-informed pharmacology monograph. Reviewed 10 November 2026. Educational material only; clinical use requires current local product labeling and patient-specific assessment. Clinical overview Budesonide is a synthetic glucocorticoid with strong topical anti-inflammatory activity and substantial hepatic first-pass metabolism. Formulations include inhaled suspensions/powders, intranasal sprays, oral modified-release preparations for selected inflammatory bowel conditions, and oral suspension/tablet products…

Read Full News

Terbutaline Monograph: Beta-2 Agonism, Bronchospasm and Prolonged Tocolysis Warning

Evidence-informed pharmacology monograph. Reviewed 10 November 2026. Educational material only; clinical use requires current local product labeling and patient-specific assessment. Overview and chemical correction Terbutaline is a selective short-acting beta-2 adrenoceptor agonist (SABA) used for prevention and reversal of bronchospasm in authorized formulations. It is a resorcinol-type phenylethanolamine, not the pyrrole-based molecule or classic catechol…

Read Full News